CD8A and neoplasm: Although it should not be concluded from these few cases that CD8+ T cells are dispensable, they suggest that for certain patients, for example when no autologous CD8+ T cell product with tumor reactivity can be derived, CD4+ T cell-based therapy could be helpful.